Christopher Cammarata

Dr. Chris Cammarata is a Principal Scientist at Johnson & Johnson Innovative Medicine, where he has worked since 2015 in the Analytical Development group. He is responsible for developing, validating, transferring, and owning release and stability methods for protein and complex therapeutics. His areas of expertise are in HPLC and capillary based method development, and he is currently the department’s Capillary Isoelectric Focusing subject matter expert.